Discovery of Non-Covalent Inhibitors for SARS-CoV-2 PLpro: Integrating Virtual Screening, Synthesis, and Experimental Validation
Bruna · 2024
Read Discovery of Non-Covalent Inhibitors for SARS-CoV-2 PLpro: Integrating Virtual Screening, Synthesis, and Experimental Validation by Bruna (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11647681.txt.
Description
A research team hunts non covalent blockers of a SARS-CoV-2 enzyme. Their study from twenty twenty-four deals with the papain like protease. The enzyme aids virus growth and immune evasion.
A virtual screen ranked compounds from an in house library. Eighty-one hits went to enzyme and binding tests. One modest blocker held a naphthyridine core at its center. Thirty analogs of that core were made and tested. Three stood out as promising non covalent blockers. Their strength sat in a mid range band. Drug like traits were checked in lab assays too.
Catalog record
| CREATOR | Bruna |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 28 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |